Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma

NCT01242930 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Imetelstat (7.5 mg/kg)
DRUG: lenalidomide standard of care
DRUG: Imetelstat (9.4 mg/kg)

Sponsor

Geron Corporation